BioInsights - Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success - spotlight

CELL & GENE THERAPY INSIGHTS

Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success

Fritz Fiesser
Guest Editor:
Fritz Fiesser, Director, C&GT Engineering and Informatics at GlaxoSmithKline
June 2021

Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success
Download PDF